What preoperative deep vein thrombosis prophylaxis should be used for patients undergoing knee arthroplasty?

Preoperative DVT Prophylaxis for Knee Arthroplasty

Do not initiate pharmacologic DVT prophylaxis preoperatively for knee arthroplasty—begin prophylaxis postoperatively, at least 12-24 hours after surgery.

Timing of Prophylaxis Initiation

The critical distinction here is preoperative versus postoperative initiation. The evidence strongly suggests avoiding preoperative pharmacologic prophylaxis:

• Preoperative LMWH significantly increases prosthetic infection risk (OR 6.2 for surgical site infections overall; 100% of prosthetic infections occurred in patients receiving preoperative LMWH versus 35% in controls) 1
• This infection risk outweighs any theoretical thrombotic benefit from earlier initiation
• The American College of Chest Physicians guidelines recommend postoperative initiation for major orthopedic surgery, specifically stating LMWH should start "12-24 h postoperatively (or after an indwelling epidural catheter has been removed)" 2222

Recommended Postoperative Prophylaxis Regimen

Once surgery is complete and the appropriate postoperative window has passed, initiate one of the following:

First-Line Options (in order of preference based on 2024 evidence):

1. Aspirin < 325 mg daily (81-162 mg)

   • Best overall safety-efficacy profile (SUCRA-VTE 89.3%, SUCRA-MBE 75.3%, SUCRA-WC 71.1%) 3
   • Start postoperatively, continue for minimum 10-14 days 2222
   • Consider extending to 35 days 2222

2. Enoxaparin (standard dosing per package insert)

   • Strong efficacy-safety balance (SUCRA-VTE 55.7%, SUCRA-MBE 49.8%) 3
   • Start 12-24 hours postoperatively 2222
   • Minimum 10-14 days, consider extending to 35 days

3. Dabigatran

   • Favorable profile (SUCRA-VTE 44.9%, SUCRA-MBE 52.0%) 3

4. Apixaban 5 mg

   • Excellent balance between VTE prevention and hemorrhage control 4
   • Most effective in reducing DVT, PE, and major hemorrhages in recent network meta-analysis 4

Alternative Options:

• Rivaroxaban 10 mg
• Fondaparinux
• Adjusted-dose warfarin (INR 2.0-3.0)

Duration of Prophylaxis

• Minimum: 10-14 days (Grade 1A recommendation) 22225
• Suggested extension: up to 35 days for optimal protection 2222

Special Considerations

Patients at Increased Bleeding Risk:

• Use intermittent pneumatic compression devices (IPCD) alone
• Avoid pharmacologic prophylaxis entirely 2222

Combined Prophylaxis:

• Consider adding mechanical prophylaxis (graduated compression stockings or IPCD) to pharmacologic agents in high-risk patients
• Early mobilization is essential regardless of agent chosen 6

Common Pitfalls to Avoid

1. Never start LMWH or other anticoagulants preoperatively—this dramatically increases prosthetic infection risk 1
2. Avoid aspirin doses ≥ 325 mg twice daily—the AAOS recommendation of 650 mg/day lacks evidence; the effective dose studied was 162 mg/day 7
3. Do not use IVC filters for primary prevention—no RCT evidence supports this 22227
4. Do not perform routine screening duplex ultrasonography—guidelines recommend against this 2222
5. Do not stop prophylaxis at hospital discharge—continue for minimum 10-14 days total, regardless of discharge timing

Algorithm Summary

Standard-risk patient:

• Start aspirin 81-162 mg daily postoperatively → Continue 10-14 days (consider 35 days)

Higher-risk patient or aspirin contraindication:

• Start enoxaparin or apixaban 12-24 hours postoperatively → Continue 10-14 days (consider 35 days)

High bleeding risk:

• IPCD alone, no pharmacologic prophylaxis